Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Point-counterpoint: what is the optimal trial design to test hyperthermia for carcinoma of the cervix? Point: addition of hyperthermia or cisplatin to radiotherapy for patients with cervical cancer; two promising combinations--no definite conclusions.
van der Zee J, Koper PC, Lutgens LC, Burger CW. van der Zee J, et al. Among authors: koper pc. Int J Hyperthermia. 2002 Jan-Feb;18(1):19-24. doi: 10.1080/02656730110083738. Int J Hyperthermia. 2002. PMID: 11824390 Free article. Review.
Long-term survival data of triple modality treatment of stage IIB-III-IVA cervical cancer with the combination of radiotherapy, chemotherapy and hyperthermia - an update.
Westermann A, Mella O, Van Der Zee J, Jones EL, Van Der Steen-Banasik E, Koper P, Uitterhoeve AL, De Wit R, Van Der Velden J, Burger C, Schem BC, Van Der Wilt C, Dahl O, Prosnitz LR, Van Tinteren H. Westermann A, et al. Int J Hyperthermia. 2012;28(6):549-53. doi: 10.3109/02656736.2012.673047. Epub 2012 Jul 13. Int J Hyperthermia. 2012. PMID: 22788973 Free article. Clinical Trial.
Radiotherapy and hyperthermia for treatment of primary locally advanced cervix cancer: results in 378 patients.
Franckena M, Lutgens LC, Koper PC, Kleynen CE, van der Steen-Banasik EM, Jobsen JJ, Leer JW, Creutzberg CL, Dielwart MF, van Norden Y, Canters RA, van Rhoon GC, van der Zee J. Franckena M, et al. Among authors: koper pc. Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):242-50. doi: 10.1016/j.ijrobp.2008.03.072. Epub 2008 Nov 5. Int J Radiat Oncol Biol Phys. 2009. PMID: 18990505 Clinical Trial.
Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial.
Franckena M, Stalpers LJ, Koper PC, Wiggenraad RG, Hoogenraad WJ, van Dijk JD, Wárlám-Rodenhuis CC, Jobsen JJ, van Rhoon GC, van der Zee J. Franckena M, et al. Among authors: koper pc. Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1176-82. doi: 10.1016/j.ijrobp.2007.07.2348. Epub 2007 Sep 19. Int J Radiat Oncol Biol Phys. 2008. PMID: 17881144 Clinical Trial.
Radiation therapy combined with hyperthermia versus cisplatin for locally advanced cervical cancer: Results of the randomized RADCHOC trial.
Lutgens LC, Koper PC, Jobsen JJ, van der Steen-Banasik EM, Creutzberg CL, van den Berg HA, Ottevanger PB, van Rhoon GC, van Doorn HC, Houben R, van der Zee J. Lutgens LC, et al. Among authors: koper pc. Radiother Oncol. 2016 Sep;120(3):378-382. doi: 10.1016/j.radonc.2016.02.010. Epub 2016 Feb 17. Radiother Oncol. 2016. PMID: 26897513 Clinical Trial.
First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma.
Westermann AM, Jones EL, Schem BC, van der Steen-Banasik EM, Koper P, Mella O, Uitterhoeve AL, de Wit R, van der Velden J, Burger C, van der Wilt CL, Dahl O, Prosnitz LR, van der Zee J. Westermann AM, et al. Cancer. 2005 Aug 15;104(4):763-70. doi: 10.1002/cncr.21128. Cancer. 2005. PMID: 15968685 Free article. Clinical Trial.
Survival after relapse in patients with endometrial cancer: results from a randomized trial.
Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC, De Winter KA, Lutgens LC, van den Bergh AC, van der Steen-Banasik E, Beerman H, van Lent M; PORTEC Study Group. Creutzberg CL, et al. Among authors: koper pc. Gynecol Oncol. 2003 May;89(2):201-9. doi: 10.1016/s0090-8258(03)00126-4. Gynecol Oncol. 2003. PMID: 12713981 Clinical Trial.
Treatment of cervical cancer.
van der Zee J, Koper PC, Lutgens LC, Burger CW. van der Zee J, et al. Among authors: koper pc. Lancet. 2002 Jan 26;359(9303):357; author reply 358. doi: 10.1016/S0140-6736(02)07518-9. Lancet. 2002. PMID: 11830236 No abstract available.
Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial.
Creutzberg CL, van Putten WL, Wárlám-Rodenhuis CC, van den Bergh AC, de Winter KA, Koper PC, Lybeert ML, Slot A, Lutgens LC, Stenfert Kroese MC, Beerman H, van Lent M; postoperative Radiation Therapy in Endometrial Carcinoma Trial. Creutzberg CL, et al. Among authors: koper pc. J Clin Oncol. 2004 Apr 1;22(7):1234-41. doi: 10.1200/JCO.2004.08.159. J Clin Oncol. 2004. PMID: 15051771 Clinical Trial.
58 results